Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

Simple item page
dc.contributor.authorda Silva, Elizabeth
dc.contributor.authorRandall, Katrina
dc.date.accessioned2015-12-10T23:12:58Z
dc.date.issued2013
dc.date.updated2024-03-03T07:17:50Z
dc.identifier.issn2213-2198
dc.identifier.urihttp://hdl.handle.net/1885/64213
dc.publisherElsevier BV
dc.sourceThe Journal of Allergy and Clinical Immunology: In Practice
dc.subjectKeywords: adrenalin; antihistaminic agent; bee venom; immunoglobulin E; omalizumab; adult; affect; agitation; allergy; anaphylaxis; article; bee sting; behavior change; blood pressure; case report; dyspnea; flushing; gene mutation; human; immunotherapy; injection s
dc.titleOmalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome
dc.typeJournal article
local.bibliographicCitation.issue6
local.bibliographicCitation.lastpage688
local.bibliographicCitation.startpage687
local.contributor.affiliationda Silva, Elizabeth, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationRandall, Katrina, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidda Silva, Elizabeth, u5300177
local.contributor.authoruidRandall, Katrina, u4259040
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110000 - MEDICAL AND HEALTH SCIENCES
local.identifier.absfor060406 - Genetic Immunology
local.identifier.ariespublicationU3488905xPUB902
local.identifier.citationvolume1
local.identifier.doi10.1016/j.jaip.2013.07.004
local.identifier.scopusID2-s2.0-84887017741
local.identifier.thomsonID000209374700021
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_da Silva_Omalizumab_mitigates_2013.pdf
Size:
82.42 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS